Taysha Gene Therapies Inc (TSHA)
3.09
-0.05
(-1.59%)
USD |
NASDAQ |
May 17, 16:00
3.08
-0.01
(-0.32%)
After-Hours: 20:00
Taysha Gene Therapies Free Cash Flow: -76.24M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -76.24M |
| December 31, 2023 | -80.39M |
| September 30, 2023 | -51.85M |
| June 30, 2023 | -62.23M |
| March 31, 2023 | -84.98M |
| December 31, 2022 | -113.26M |
| September 30, 2022 | -174.44M |
| Date | Value |
|---|---|
| June 30, 2022 | -178.54M |
| March 31, 2022 | -168.39M |
| December 31, 2021 | -138.60M |
| September 30, 2021 | -115.72M |
| June 30, 2021 | -86.53M |
| March 31, 2021 | -60.68M |
| December 31, 2020 | -30.73M |
Free Cash Flow Range, Past 5 Years
-178.54M
Minimum
Jun 2022
-30.73M
Maximum
Dec 2020
-101.61M
Average
-85.75M
Median
Free Cash Flow Benchmarks
| Aquestive Therapeutics Inc | -26.60M |
| Lifecore Biomedical Inc | -- |
| Relmada Therapeutics Inc | -48.19M |
| ACADIA Pharmaceuticals Inc | 63.71M |
| Cyclacel Pharmaceuticals Inc | -16.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -19.80M |
| Cash from Investing (Quarterly) | -0.14M |
| Cash from Financing (Quarterly) | -0.022M |
| Free Cash Flow Per Share (Quarterly) | -0.0862 |
| Free Cash Flow to Equity (Quarterly) | -19.94M |
| Free Cash Flow Yield | -16.23% |